Table 2.
Correlations between combined fascin and BRMS1 expression status and clinicopathological features
| Parameter | Fascin-/BRMS1+ | Fascin+/BRMS1- | p-value | |
|---|---|---|---|---|
| n=99 | n=18 | |||
| Age | <50 | 61 (61.6) | 13 (72.2) | 0.439 |
| ≥50 | 38 (38.4) | 5 (27.8) | ||
| Tumor stage | pT1 | 49 (49.5) | 8 (44.4) | 0.800 |
| pT2-3 | 50 (50.5) | 10 (55.6) | ||
| Nodal stage | pN0 | 49 (49.5) | 14 (77.8) | 0.038 |
| pN1-3 | 50 (50.5) | 4 (22.2) | ||
| AJCC stage | I | 79 (79.8) | 15 (83.3) | 1.000 |
| II-III | 20 (20.2) | 3 (16.7) | ||
| Histologic grade | 1 | 21 (21.2) | 0 (0.0) | 0.040 |
| 2/3 | 78 (78.8) | 18 (100.0) | ||
| Nuclear grade | 1 | 44 (44.4) | 2 (11.1) | 0.008 |
| 2/3 | 55 (55.6) | 16 (88.9) | ||
| Lymphovasculr invasion | Absent | 40 (40.4) | 10 (55.6) | 0.302 |
| Present | 59 (59.6) | 8 (44.4) | ||
| ER | Positive | 75 (75.8) | 0 (0.0) | <0.001 |
| Negative | 24 (24.2) | 18 (100.0) | ||
| PR | Positive | 59 (59.6) | 0 (0.0) | <0.001 |
| Negative | 40 (40.4) | 18 (100.0) | ||
| HER2 | Negative | 73 (73.7) | 17 (94.4) | 0.069 |
| Positive | 26 (26.3) | 1 (5.6) | ||
| Intrinsic subtype | Luminal A | 63 (63.6) | 0 (0.0) | < 0.001 |
| Luminal B | 13 (13.1) | 0 (0.0) | ||
| HER2 | 13 (13.1) | 1 (5.6) | ||
| Triple-negative | 10 (10.1) | 17 (94.4) | ||
| Tumor recurrence | Present | 83 (83.8) | 16 (88.9) | 0.738 |
| Patients death | Present | 12 (12.1) | 3 (16.7) | 0.700 |